- Home
- THW vs SVRA Comparison
THW vs SVRA Comparison
Compare THW & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THW
- SVRA
- Stock Information
- Founded
- THW 2015
- SVRA 2007
- Country
- THW United States
- SVRA United States
- Employees
- THW N/A
- SVRA N/A
- Industry
- THW Finance Companies
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- THW Finance
- SVRA Health Care
- Exchange
- THW Nasdaq
- SVRA Nasdaq
- Market Cap
- THW 473.6M
- SVRA 527.2M
- IPO Year
- THW N/A
- SVRA N/A
- Fundamental
- Price
- THW $12.98
- SVRA $3.38
- Analyst Decision
- THW
- SVRA Buy
- Analyst Count
- THW 0
- SVRA 8
- Target Price
- THW N/A
- SVRA $6.63
- AVG Volume (30 Days)
- THW 149.9K
- SVRA 1.1M
- Earning Date
- THW 01-01-0001
- SVRA 11-11-2025
- Dividend Yield
- THW 10.76%
- SVRA N/A
- EPS Growth
- THW N/A
- SVRA N/A
- EPS
- THW N/A
- SVRA N/A
- Revenue
- THW N/A
- SVRA N/A
- Revenue This Year
- THW N/A
- SVRA N/A
- Revenue Next Year
- THW N/A
- SVRA N/A
- P/E Ratio
- THW N/A
- SVRA N/A
- Revenue Growth
- THW N/A
- SVRA N/A
- 52 Week Low
- THW $9.76
- SVRA $1.89
- 52 Week High
- THW $14.89
- SVRA $4.30
- Technical
- Relative Strength Index (RSI)
- THW 70.57
- SVRA 50.12
- Support Level
- THW $12.72
- SVRA $3.35
- Resistance Level
- THW $13.05
- SVRA $3.53
- Average True Range (ATR)
- THW 0.23
- SVRA 0.12
- MACD
- THW 0.02
- SVRA -0.04
- Stochastic Oscillator
- THW 94.44
- SVRA 18.03
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.